These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38354919)

  • 21. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.
    Netter RC; Amberg SM; Balliet JW; Biscone MJ; Vermeulen A; Earp LJ; White JM; Bates P
    J Virol; 2004 Dec; 78(24):13430-9. PubMed ID: 15564453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Designing Self-Inhibitory fusion peptide analogous to viral spike protein against novel severe acute respiratory syndrome (SARS-CoV-2).
    Singh I; Singh S; Ojha KK; Yadav NS
    J Biomol Struct Dyn; 2022; 40(21):11357-11372. PubMed ID: 34379031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of recombinant protein-based SARS-CoV entry inhibitors targeting the heptad-repeat regions of the spike protein S2 domain.
    Ni L; Zhu J; Zhang J; Yan M; Gao GF; Tien P
    Biochem Biophys Res Commun; 2005 Apr; 330(1):39-45. PubMed ID: 15781229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern.
    Xing L; Xu X; Xu W; Liu Z; Shen X; Zhou J; Xu L; Pu J; Yang C; Huang Y; Lu L; Jiang S; Liu S
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repurposing fusion inhibitor peptide against SARS-CoV-2.
    Efaz FM; Islam S; Talukder SA; Akter S; Tashrif MZ; Ali MA; Sufian MA; Parves MR; Islam MJ; Halim MA
    J Comput Chem; 2021 Dec; 42(32):2283-2293. PubMed ID: 34591335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solution structure of the severe acute respiratory syndrome-coronavirus heptad repeat 2 domain in the prefusion state.
    Hakansson-McReynolds S; Jiang S; Rong L; Caffrey M
    J Biol Chem; 2006 Apr; 281(17):11965-71. PubMed ID: 16507566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural conservation among variants of the SARS-CoV-2 spike postfusion bundle.
    Yang K; Wang C; White KI; Pfuetzner RA; Esquivies L; Brunger AT
    Proc Natl Acad Sci U S A; 2022 Apr; 119(16):e2119467119. PubMed ID: 35363556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus.
    Ingallinella P; Bianchi E; Finotto M; Cantoni G; Eckert DM; Supekar VM; Bruckmann C; Carfi A; Pessi A
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8709-14. PubMed ID: 15161975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus.
    Gao J; Lu G; Qi J; Li Y; Wu Y; Deng Y; Geng H; Li H; Wang Q; Xiao H; Tan W; Yan J; Gao GF
    J Virol; 2013 Dec; 87(24):13134-40. PubMed ID: 24067982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronavirus escape from heptad repeat 2 (HR2)-derived peptide entry inhibition as a result of mutations in the HR1 domain of the spike fusion protein.
    Bosch BJ; Rossen JW; Bartelink W; Zuurveen SJ; de Haan CA; Duquerroy S; Boucher CA; Rottier PJ
    J Virol; 2008 Mar; 82(5):2580-5. PubMed ID: 18077706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of Spike protein and lipid membrane of SARS-CoV-2 with Ursodeoxycholic acid, an in-silico analysis.
    Rodal Canales FJ; Pérez-Campos Mayoral L; Hernández-Huerta MT; Sánchez Navarro LM; Matias-Cervantes CA; Martínez Cruz M; Cruz Parada E; Zenteno E; Ramos-Martínez EG; Pérez-Campos Mayoral E; Romero Díaz C; Pérez-Campos E
    Sci Rep; 2021 Nov; 11(1):22288. PubMed ID: 34782703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the membrane-active regions of the severe acute respiratory syndrome coronavirus spike membrane glycoprotein using a 16/18-mer peptide scan: implications for the viral fusion mechanism.
    Guillén J; Pérez-Berná AJ; Moreno MR; Villalaín J
    J Virol; 2005 Feb; 79(3):1743-52. PubMed ID: 15650199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus.
    Sun Y; Zhang H; Shi J; Zhang Z; Gong R
    Viruses; 2017 Sep; 9(9):. PubMed ID: 28906430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central ions and lateral asparagine/glutamine zippers stabilize the post-fusion hairpin conformation of the SARS coronavirus spike glycoprotein.
    Duquerroy S; Vigouroux A; Rottier PJ; Rey FA; Bosch BJ
    Virology; 2005 May; 335(2):276-85. PubMed ID: 15840526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and characterization of novel SARS-CoV-2 fusion inhibitors with N-terminally extended HR2 peptides.
    Hu Y; Zhu Y; Yu Y; Liu N; Ju X; Ding Q; He Y
    Antiviral Res; 2023 Apr; 212():105571. PubMed ID: 36868315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stapled Peptides Targeting SARS-CoV-2 Spike Protein HR1 Inhibit the Fusion of Virus to Its Cell Receptor.
    Zheng M; Cong W; Peng H; Qing J; Shen H; Tang Y; Geng C; Chen S; Zou Y; Zhang WD; Hu HG; Li X
    J Med Chem; 2021 Dec; 64(23):17486-17495. PubMed ID: 34818014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trimeric, coiled-coil extension on peptide fusion inhibitor of HIV-1 influences selection of resistance pathways.
    Zhuang M; Wang W; De Feo CJ; Vassell R; Weiss CD
    J Biol Chem; 2012 Mar; 287(11):8297-309. PubMed ID: 22235115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dimerized fusion inhibitor peptides targeting the HR1-HR2 interaction of SARS-CoV-2.
    Tsuji K; Baffour-Awuah Owusu K; Miura Y; Ishii T; Shinohara K; Kobayakawa T; Emi A; Nakano T; Suzuki Y; Tamamura H
    RSC Adv; 2023 Mar; 13(13):8779-8793. PubMed ID: 36950081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion.
    Wang E; Sun X; Qian Y; Zhao L; Tien P; Gao GF
    Biochem Biophys Res Commun; 2003 Mar; 302(3):469-75. PubMed ID: 12615056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core.
    Xu Y; Lou Z; Liu Y; Pang H; Tien P; Gao GF; Rao Z
    J Biol Chem; 2004 Nov; 279(47):49414-9. PubMed ID: 15345712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.